Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;117(1):190-9.
doi: 10.1093/toxsci/kfq192. Epub 2010 Jun 27.

Genomic and proteomic responses to environmentally relevant exposures to dieldrin: indicators of neurodegeneration?

Affiliations

Genomic and proteomic responses to environmentally relevant exposures to dieldrin: indicators of neurodegeneration?

Christopher J Martyniuk et al. Toxicol Sci. 2010 Sep.

Abstract

Dieldrin is a persistent organochlorine pesticide that induces neurotoxicity in the vertebrate central nervous system and impairs reproductive processes in fish. This study examined the molecular events produced by subchronic dietary exposures to 2.95 mg dieldrin/kg feed in the neuroendocrine brain of largemouth bass, an apex predator. Microarrays, proteomics, and pathway analysis were performed to identify genes, proteins, and cell processes altered in the male hypothalamus. Fifty-four genes were induced, and 220 genes were reduced in steady-state levels (p < 0.001; fold change greater than +/- 1.5). Functional enrichment analysis revealed that the biological gene ontology categories of stress response, nucleotide base excision repair, response to toxin, and metabolic processes were significantly impacted by dieldrin. Using isobaric tagging for relative and absolute quantitation, 90 proteins in the male hypothalamus were statistically evaluated for changes in protein abundance. Several proteins altered by dieldrin are known to be associated with human neurodegenerative diseases, including apolipoprotein E, microtubule-associated tau protein, enolase 1, stathmin 1a, myelin basic protein, and parvalbumin. Proteins altered by dieldrin were involved in oxidative phosphorylation, differentiation, proliferation, and cell survival. This study demonstrates that a subchronic exposure to dieldrin alters the abundance of messenger RNAs and proteins in the hypothalamus that are associated with cell metabolism, cell stability and integrity, stress, and DNA repair.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Disease processes that involve genes (p < 0.01) regulated by dieldrin. Green indicates a downregulation in the mRNA and red indicates an induction in mRNA level. Proteins in figure follow nomenclature rules for mammalian proteins because pathways are based on mammalian data. 101F6, cytochrome b-561 domain containing 2; ABCF2, ATP-binding cassette, subfamily F (GCN20), member 2 (predicted); AMACR, alpha-methylacyl-CoA racemase; APCS, serum amyloid P-component; APOH, apolipoprotein H; ATF2, activating transcription factor 2; ATP2B1, ATPase, Ca++ transporting, plasma membrane 1; Bmp7, bone morphogenetic protein 7; C1D, nuclear DNA-binding protein; Calu, calumenin; CDK10, cyclin-dependent kinase (CDC2-like) 10; CDW92, CDW92 antigen; CEBPD, CCAAT/enhancer-binding protein (C/EBP), delta; CENPE, centromere protein E (predicted); CLDN1, claudin 1; CYCS, cytochrome c, somatic; DLG2, discs, large homolog 2 (Drosophila); ESR2, estrogen receptor 2 beta; FGF12, fibroblast growth factor 12; FLJ10140, tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase (predicted); GTR2, Ras-related GTP binding C (predicted); HLA-DRB3, major histocompatibility complex, class II, DR beta 3; HRMT1L2, heterogeneous nuclear ribonucleoprotein methyltransferase-like 2 (Saccharomyces cerevisiae); HSPC167, CDK5 regulatory subunit associated protein 1; KLKB1, kallikrein B, plasma 1; KRT15, type I keratin KA15; MDK, midkine; MGC9788, 3-hydroxybutyrate dehydrogenase, type 1; MYO9B, myosin Ixb; NAPB, similar to N-ethylmaleimide-sensitive fusion protein attachment protein beta; NPC2, Niemann-Pick type C2; OXCT1, similar to 3-oxoacid CoA transferase 1; P2RY12, purinergic receptor P2Y, G-protein coupled 12; PFKL, phosphofructokinase, liver, B-type; PLP1, proteolipid protein; POMC, pro-opiomelanocortin; PPAP2B, phosphatidic acid phosphatase type 2B; PPGB, protective protein for beta-galactosidase; RDH11, retinol dehydrogenase 11; RFT1, RFT1 homolog (predicted); SERPINB9, similar to SPI6; SH3BGRL3, SH3 domain binding glutamic acid–rich protein-like 3 (predicted); SNAP25, synaptosome-associated protein 25 kDa; SNM1, DNA cross-link repair 1A, PSO2 homolog (S. cerevisiae) (predicted); SOAT1, sterol O-acyltransferase 1; SRPR, hypothetical LOC569063; TACC1, transforming, acidic coiled-coil containing protein 1; TACSTD1, tumor-associated calcium signal transducer 1; TPRT, prenyl (solanesyl) diphosphate synthase, subunit 1.
FIG. 2.
FIG. 2.
Relative fold changes for genes analyzed by microarray (white bars; n = 4) and real-time PCR (black bars; n = 4) in the male hypothalamus. Abbreviations are as follows: ar = androgen receptor; esrβb = estrogen receptor beta b; gpx = glutathione peroxidase; gst = glutathione-s-transferase; hsp70= heat-shock protein 70; npc2 = Niemann-Pick Disease C2.

Similar articles

Cited by

References

    1. Al-Shahrour F, Mínguez P, Vaquerizas JM, Conde L, Dopazo J. Babelomics: a suite of web-tools for functional annotation and analysis of group of genes in high-throughput experiments. Nucleic Acids Res. 2005;33:W460–W464. - PMC - PubMed
    1. Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson’s disease—is there a link? Environ. Health Perspect. 2006;114:156–164. - PMC - PubMed
    1. Chen L, Yung WH. GABAergic neurotransmission in globus pallidus and its involvement in neurologic disorders. Sheng Li Xue Bao. 2004;56:427–435. - PubMed
    1. Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson’s disease. J. Toxicol. Environ. Health A. 2000;59:229–234. - PubMed
    1. De Iuliis A, Grigoletto J, Recchia A, Giusti P, Arslan P. A proteomic approach in the study of an animal model of Parkinson’s disease. Clin. Chim. Acta. 2005;357:202–209. - PubMed

Publication types